A Clinical Study to Assess the Safety and Effectiveness of Utixira Lotion and Utixira Tablet in Healthy Adult Human Subjects With Dry or Sensitive Skin Prone to Mild to Moderate Pruritus and Urticaria

Inclusion Criteria

• •Age: 18 to 55 years (both inclusive) at the time of consent.
• •Sex: Healthy male and non-pregnant/non-lactating females.
• •Females of childbearing potential must have a self-reported negative pregnancy test.
• •Subject are generally in good health.
• •Subject with dry or sensitive skin at a time of screening. (Dermatological Assessment)
• •Subjects having pruritus or urticaria at a time of screening.
• •Subjects application site must be free of cuts, tattoos, scratches, abrasions, scars, uneven skin tone, sunburn, excessive tan, excessive hair or open wounds.
• •Subject is able to remain on stable doses of contraceptive or replacement hormonal therapy, including no therapy, 6 weeks prior to and for the duration of the study.
• •If the subject is of childbearing potential, is practicing and agrees to maintain an established method of birth control (IUD, hormonal implant device/injection, regular use of birth control pills or patch, diaphragm, condoms with spermicide or sponge with spermicidal jelly, cream or foam, partner vasectomy or abstinence). Females will be considered as non-childbearing potential if they are surgically sterile, have been post-menopausal for at least 1 year or have had a tubal ligation.
• •Subjects are willing to give written informed consent and are willing to come for regular follow up.
• •Subjects who commit not to use medicated skincare product other than the test product for the entire duration of the study.
• •Subject who have not participated in a similar investigation in the past three months.
• •Willing to use test product throughout the study period.